Pancreatic tumors ‘reprogrammed’ by new vaccine

Researchers from the Johns Hopkins University School of Medicine in Baltimore, MD, have discovered that a combination of a vaccine and low-dose chemotherapy may make pancreatic cancer susceptible to the effects of immunotherapy. These findings are significant because, typically, these cancers do not respond to immunotherapy, with fewer than 5% of patients surviving 5 years after diagnosis. Read more

In pancreatic cancers, gene discovery links cancer cell ‘recycling’ system to potential new therapy

The latest study has discovered a gene with a critical link to pancreatic cancer, and further investigation in mice shows that by blocking the gene’s most important function, researchers can slow the disease and extend survival. Read more

Combating cancer in China

China’s most prominent institute for cancer research says it’s conducting clinical trials on a drug that could improve the treatment of pancreatic cancer. This is one of many measures that China has launched to combat escalating cases year on year. China is also taking an active role in the global fight to reduce stigma and cut costs. Read more

CT scans predict chemotherapy response in pancreatic cancer

Computed tomography (CT) scans routinely taken to guide the treatment of pancreatic cancer may provide an important secondary benefit. According to new research from The University of Texas MD Anderson Cancer Center, the scans also reflect how well chemotherapy will penetrate the tumor, predicting the effectiveness of treatment. Read more